Jazz Pharmaceuticals plc (JAZZ): Depreciation & Amortization
$41.60M
Year ended 2025-12-31
+11.1%
3-year compound annual growth
+17.3%
5-year compound annual growth
+15.4%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.60M | +26.8% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $32.80M | +7.9% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $30.40M | +0.3% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $30.30M | +13.5% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $26.70M | +42.8% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $18.70M | +22.2% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $15.30M | +0.7% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $15.20M | +16.0% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $13.10M | +11.0% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $11.80M | +19.2% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $9.90M | n/a | 2018-02-27, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $41.60M | +26.8% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $337.50M | +3.6% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $55.66M | -1.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $79.56M | -17.5% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $85.60M | +18.1% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $44.52M | +18.0% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
Compare JAZZ, PRGO, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗